|
PLRX
|
Pliant Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.07%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
ERAS
|
Erasca, Inc
|
0.07%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
YMAB
|
Y-mAbs Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
RLMD
|
Relmada Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.06%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
0.06%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.06%
|
US
|
NASDAQ
|
|
EOLS
|
Evolus, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
CSTL
|
Castle Biosciences, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.06%
|
US
|
NASDAQ
|
|
TIL
|
Instil Bio, Inc.
|
0.06%
|
US
|
NASDAQ
|